Search

Author/Creator Rowe, Paul J.

1. AROMA: real-world global registry of dupilumab for chronic rhinosinusitis with nasal polyps. Issue 4 (28th November 2022)

Authors:
Siddiqui, Shahid; Bachert, Claus; Chaker, Adam M.; Han, Joseph K.; Hellings, Peter W.; Peters, Anju T.; Heffler, Enrico; Kamat, Siddhesh; Zhang, Haixin; Nash, Scott; Khan, Asif H.; De Prado Gomez, Lucia; Jacob-Nara, Juby A.; Rowe, Paul J.; Deniz, Yamo
Journal:
ERJ open research
Issue:
Volume 8:Issue 4(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Dupilumab efficacy and biomarkers in chronic rhinosinusitis with nasal polyps: Association between dupilumab treatment effect on nasal polyp score and biomarkers of type 2 inflammation in patients with chronic rhinosinusitis with nasal polyps in the phase 3 SINUS‐24 and SINUS‐52 trials. Issue 9 (31st January 2022)

Authors:
Bachert, Claus; Corren, Jonathan; Lee, Stella E.; Zhang, Haixin; Harel, Sivan; Cunoosamy, Danen; Khan, Asif H.; Jacob‐Nara, Juby A.; Siddiqui, Shahid; Nash, Scott; Rowe, Paul J.; Deniz, Yamo
Journal:
International forum of allergy & rhinology
Issue:
Volume 12:Issue 9(2022)
Page Start:
1191
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Dupilumab efficacy and safety in Latin American patients with uncontrolled, moderate-to-severe asthma: phase 3 LIBERTY ASTHMA QUEST study. (4th May 2023)

Authors:
Maspero, Jorge F.; Cardona, Guido; Schonffeldt, Patricia; Tolcachier, Alberto; González-Diaz, Sandra N.; Yañez, Anahi; Galvao, Clovis E.; Msihid, Jerome; Gall, Rebecca; Siddiqui, Shahid; Rowe, Paul J.; Deniz, Yamo; Jacob-Nara, Juby A.; Djandji, Michel
Journal:
Journal of asthma
Issue:
Volume 60:Number 5(2023)
Page Start:
981
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Dupilumab efficacy and safety in patients with asthma and blood eosinophils ≥500 cells·µL−1. Issue 6 (23rd June 2022)

Authors:
Rabe, Klaus F.; Pavord, Ian D.; Castro, Mario; Wechsler, Michael E.; Daizadeh, Nadia; Kapoor, Upender; Ortiz, Benjamin; Radwan, Amr; Johnson, Robert R.; Rowe, Paul J.; Deniz, Yamo; Jacob-Nara, Juby A.
Journal:
European respiratory journal
Issue:
Volume 59:Issue 6(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Dupilumab efficacy in adolescents with uncontrolled, moderate‐to‐severe asthma: LIBERTY ASTHMA QUEST. Issue 8 (10th May 2021)

Authors:
Maspero, Jorge F.; FitzGerald, John Mark; Pavord, Ian D.; Rice, Megan S.; Maroni, Jaman; Rowe, Paul J.; Pirozzi, Gianluca; Amin, Nikhil; Ruddy, Marcella; Graham, Neil M. H.; Teper, Ariel; Hardin, Megan
Journal:
Allergy
Issue:
Volume 76:Issue 8(2021)
Page Start:
2621
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Dupilumab efficacy in subgroups of type 2 asthma with high-dose inhaled corticosteroids at baseline. (October 2022)

Authors:
Bourdin, Arnaud; Virchow, J. Christian; Papi, Alberto; Lugogo, Njira L.; Bardin, Philip; Antila, Martti; Halpin, David M.G.; Daizadeh, Nadia; Djandji, Michel; Ortiz, Benjamin; Jacob-Nara, Juby A.; Gall, Rebecca; Deniz, Yamo; Rowe, Paul J.
Journal:
Respiratory medicine
Issue:
Volume 202(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Dupilumab reduced impact of severe exacerbations on lung function in patients with moderate‐to‐severe type 2 asthma. Issue 1 (9th August 2022)

Authors:
Papi, Alberto; Corren, Jonathan; Castro, Mario; Domingo, Christian; Rogers, Linda; Chapman, Kenneth R.; Jackson, Daniel J.; Daizadeh, Nadia; Pandit‐Abid, Nami; Gall, Rebecca; Jacob‐Nara, Juby A.; Rowe, Paul J.; Deniz, Yamo; Ortiz, Benjamin
Journal:
Allergy
Issue:
Volume 78:Issue 1(2023)
Page Start:
233
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Long-term effect of dupilumab on prevention of lung function decline in patients with uncontrolled moderate-to-severe asthma: ATLAS trial design. Issue 2 (6th March 2023)

Authors:
De Prado Gomez, Lucia; Pavord, Ian; Busse, William; Brightling, Christopher E.; Wechsler, Michael E.; Rabe, Klaus F.; Zhang, Mei; Xing, Jun; Jacob-Nara, Juby A.; Rowe, Paul J.
Journal:
ERJ open research
Issue:
Volume 9:Issue 2(2023)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Rapid and sustained effects of dupilumab in severe chronic rhinosinusitis with nasal polyps. Issue 7 (23rd January 2022)

Authors:
Hellings, Peter W.; Peters, Anju T.; Chaker, Adam M.; Heffler, Enrico; Zhang, Haixin; Praestgaard, Amy; Nash, Scott; Khan, Asif H.; Siddiqui, Shahid; Jacob‐Nara, Juby A.; Rowe, Paul J.; Deniz, Yamo
Journal:
International forum of allergy & rhinology
Issue:
Volume 12:Issue 7(2022)
Page Start:
958
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗